throbber
Case IPR2015-01624
`U.S. Patent No. 6,331,415
`Filed on behalf of: Sanofi Aventis U.S. LLC and Regeneron Pharmaceuticals, Inc.
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________________________________
`
`SANOFI-AVENTIS U.S. LLC AND
`REGENERON PHARMACEUTICALS, INC.,
`Petitioners
`
`v.
`
`GENENTECH, INC. AND CITY OF HOPE,
`Patent Owners
`____________________________________
`
`Case IPR2015-01624
`Patent 6,331,415
`
`____________________________________
`
`PETITIONERS’ CURRENT EXHIBIT LIST
`
`

`
`Case IPR2015-01624
`U.S. Patent No. 6,331,415
`PETITIONERS’ CURRENT EXHIBIT LIST
`
`Pursuant to 37 C.F.R. § 42.63(e), Petitioners Sanofi Aventis U.S. LLC
`
`(“Sanofi”) and Regeneron Pharmaceuticals, Inc. (“Regeneron”) (collectively,
`
`“Petitioners”) hereby submit a current list of exhibits.
`
`Exhibit
`No.
`
`Description
`
`1001
`
`1002
`
`1003
`
`1004
`
`1005
`
`1006
`
`1007
`
`1008
`
`1009
`
`1010
`
`1011
`
`1012
`
`1013
`
`U.S. Patent No. 6,331,415
`
`U.S. Patent No. 4,495,280
`
`Riggs and Itakura, Synthetic DNA and Medicine, American Journal
`of Human Genetics, 31:531-538 (1979)
`Southern and Berg, Transformation of Mammalian Cells to
`Antibiotic Resistance with a Bacterial Gene Under Control of the
`SV40 Early Region Promoter, Journal of Molecular and Applied
`Genetics, 1:327-341 (1982)
`U.S. Patent No. 4,237,224
`
`Declaration of Jefferson Foote, Ph.D., in Support of Sanofi And
`Regeneron's Petition for Inter Partes Review of U.S. Patent No.
`6,331,415
`
`U.S. Patent No. 4,816,657
`
`'415 patent reexamination, Office Action dated 2/16/07
`
`'415 patent reexamination, Owners' Resp. dated 11/25/05
`
`'415 patent reexamination, Owners' Resp. (5/21/07)
`
`'415 patent reexamination, Office Action dated 9/13/05
`
`U.S. Patent No. 4,816,397
`
`'415 patent file history, paper no. 17
`
`

`
`Case IPR2015-01624
`U.S. Patent No. 6,331,415
`Exhibit
`No.
`
`Description
`
`1014
`
`1015
`
`1016
`
`1017
`
`1018
`
`1019
`
`1020
`
`1021
`
`1022
`
`1023
`
`1024
`
`1025
`
`1026
`
`1027
`
`1028
`
`1029
`
`'415 patent file history, paper no. 14
`
`'415 patent file history, paper no. 18
`
`'415 patent reexamination, Office Action dated 8/16/06
`
`'415 patent reexamination, Office Action dated 2/25/08
`
`U.S. Patent No. 4,399,216
`
`U.S. Patent No. 5,840,545
`
`Rice and Baltimore, Regulated Expression of an Immunoglobulin K
`Gene Introduced into a Mouse Lymphoid Cell Line, Proceedings of
`the National Academy of Sciences USA, 79:7862-7865 (1982)
`
`Ochi et al., Transfer of a Cloned Immunoglobulin Light-Chain Gene
`to Mutant Hybridoma Cells Restores Specific Antibody Production,
`Nature, 302:340-342 (1983)
`
`'415 patent reexamination, Owners' Resp. dated 10/30/06
`
`'415 patent reexamination, Owners' Resp. dated 6/6/08
`
`'415 patent reexamination, Appeal Brief
`
`'415 patent reexamination, Notice of Intent to Issue Ex Parte
`Reexamination Certificate
`
`'415 reexamination, Ex Parte Reexamination Certificate
`
`T.J.R. Harris, Expression of Eukaryotic Genes in E. Coli, in Genetic
`Engineering 4, 127-185 (1983)
`
`'415 patent reexamination, Declaration of Dr. Timothy John Roy
`Harris under 37 C.F.R. § 1.132
`
`Kabat et al., Sequences of Proteins of Immunological Interest (1983)
`(excerpt)
`
`

`
`Case IPR2015-01624
`U.S. Patent No. 6,331,415
`Exhibit
`No.
`
`Description
`
`1030
`
`1031
`
`1032
`
`1033
`
`1034
`
`1035
`
`1036
`
`1037
`
`1038
`
`1039
`
`1040
`
`1041
`
`1042
`
`1043
`
`Cohen, Recombinant DNA: Fact and Fiction, Science, 195:654-657
`(1977)
`
`Oi et al., Immunoglobulin Gene Expression in Transformed
`Lymphoid Cells, Proceedings of the National Academy of Sciences
`USA, 80:825-829 (1983)
`
`European Patent Application Publication No. 0044722 A1, published
`1/27/82
`
`U.S. Patent No. 4,487,835
`
`U.S. Patent No. 4,371,614
`
`U.S. Patent No. 4,762,785
`
`U.S. Patent No. 4,476,227
`
`U.S. Patent No. 4,362,867
`
`U.S. Patent No. 4,396,601
`
`Milstein, Monoclonal Antibodies from Hybrid Myelomas,
`Proceedings of the Royal Society of London, 211:393-412 (1981)
`
`Ochi et al., Functional Immunoglobulin M Production after
`Transfection of Cloned Immunoglobulin Heavy and Light Chain
`Genes into Lymphoid Cells, Proceedings of the National Academy of
`Sciences USA, 80:6351-6355 (1983)
`
`MedImmune, Inc. v. Genentech, Inc., No. 03-02567 (C.D. Cal. Aug.
`17, 2007), Expert Report of E. Fintan Walton
`
`'415 patent reexamination, Request for Reconsideration and/or
`Petition Under 37 C.F.R. § 1.183 dated 5/15/09
`
`Feldman et al., Lessons from the Commercialization of the Cohen-
`Boyer Patents: The Stanford University Licensing Program, in
`Intellectual Property Management in Health and Agricultural
`
`

`
`Case IPR2015-01624
`U.S. Patent No. 6,331,415
`Exhibit
`No.
`
`Description
`
`Innovation: A Handbook of Best Practices, 1797-1807 (2007)
`ReoPro® Prescribing Information
`
`Genentech v. Centocor, No. 94-01379 (N.D. Cal.), Affidavit of John
`Ghrayeb, Ph.D.
`
`'415 patent reexamination, Declaration of Dr. E. Fintan Walton under
`37 C.F.R. § 1.132
`
`Complaint in MedImmune v. Genentech, No. 03-02567 (C.D. Cal.)
`
`Stipulation and order of dismissal in MedImmune v. Genentech, No.
`03-02567 (C.D. Cal.)
`
`Complaint in Centocor v. Genentech, No. 08-CV-3573 (C.D. Cal.)
`
`Order of dismissal in Centocor v. Genentech, No. 08-CV-3573 (C.D.
`Cal.)
`
`Complaint in Glaxo Group Ltd. v. Genentech, No. 10-02764 (C.D.
`Cal.)
`
`Order of dismissal in Glaxo Group Ltd. v. Genentech, No. 10-02764
`(C.D. Cal.)
`
`Complaint in Human Genome Sciences v. Genentech, No. 11-CV-
`6519 (C.D. Cal.)
`
`Order of dismissal in Human Genome Sciences v. Genentech, No.
`11-CV-6519 (C.D. Cal.)
`
`Complaint in Eli Lilly and ImClone Systems LLC v. Genentech, No.
`13-CV-7248 (C.D. Cal.)
`
`Stipulation of dismissal in Eli Lilly and ImClone Systems LLC v.
`Genentech, No. 13-CV-7248 (C.D. Cal.)
`
`Complaint in Bristol-Myers Squibb v. Genentech, No. 13-CV-5400
`(C.D. Cal.)
`
`1044
`
`1045
`
`1046
`
`1047
`
`1048
`
`1049
`
`1050
`
`1051
`
`1052
`
`1053
`
`1054
`
`1055
`
`1056
`
`1057
`
`

`
`Case IPR2015-01624
`U.S. Patent No. 6,331,415
`Exhibit
`No.
`
`Description
`
`1058
`
`1059
`
`Stipulation of dismissal in Bristol-Myers Squibb v. Genentech, No.
`13-CV-5400 (C.D. Cal.)
`
`Declaration of Lisa M. Ferri in Support of Motion to Appear Pro
`Hac Vice on Behalf of Petitioners Sanofi-Aventis U.S. LLC and
`Regeneron Pharmaceuticals
`
`1060
`
`Professional Profile of Lisa M. Ferri
`
`Dated: August 31, 2015
`
`Respectfully submitted,
`
`By:
`Richard McCormick (Reg. No. 55,902)
`Lisa M. Ferri (pro hac vice)
`Brian W. Nolan (Reg. No. 45,821)
`MAYER BROWN LLP
`1221 Avenue of the Americas
`New York, NY 10020-1001
`Attorneys for Petitioners sanofi-aventis U.S.
`LLC and Regeneron Pharmaceuticals, Inc.
`
`

`
`Case IPR2015-01624
`U.S. Patent No. 6,331,415
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that true and correct copies of the foregoing Petitioners’
`Current Exhibit List was served on August 31, 2015, via UPS OVERNIGHT
`service to counsel for Patent Owners at the following address:
`
`Adam R. Brausa (Reg. No. 60,287)
`Daralyn Durie (pro hac pending)
`Durie Tangri LLP
`217 Leidesdorff Street
`San Francisco, CA 94111
`
`Dated: August 31, 2015
`
`Respectfully submitted,
`
`/Richard J. McCormick/
`Richard J. McCormick, (No. 55,902)
`rmccormick@mayerbrown.com
`MAYER BROWN LLP
`1221 Avenue of the Americas
`New York, NY 10020-1001
`Telephone: (212) 506-2382
`Fax: (212) 849 5682

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket